BCRX logo

BioCryst Pharmaceuticals (BCRX) Short term debt

Annual short term debt:

$2.77M+$124.00K(+4.68%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BCRX annual short term debt is $2.77 million, with the most recent change of +$124.00 thousand (+4.68%) on December 31, 2024.
  • During the last 3 years, BCRX annual short term debt has risen by +$953.00 thousand (+52.39%).
  • BCRX annual short term debt is now -93.06% below its all-time high of $39.96 million, reached on December 31, 2019.

Performance

BCRX Short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXbalance sheet metrics

quarterly short term debt:

$2.87M+$94.00K(+3.39%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BCRX quarterly short term debt is $2.87 million, with the most recent change of +$94.00 thousand (+3.39%) on March 31, 2025.
  • Over the past year, BCRX quarterly short term debt has increased by +$126.00 thousand (+4.60%).
  • BCRX quarterly short term debt is now -94.26% below its all-time high of $49.96 million, reached on September 30, 2020.

Performance

BCRX quarterly short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXbalance sheet metrics

Short term debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

BCRX Short term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+4.7%+4.6%
3 y3 years+52.4%+37.7%
5 y5 years-93.1%-93.6%

BCRX Short term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+52.4%-0.8%+37.7%
5 y5-year-93.1%+52.4%-94.3%+57.6%
alltimeall time-93.1%>+9999.0%-94.3%>+9999.0%

BCRX Short term debt History

DateAnnualQuarterly
Mar 2025
-
$2.87M(+3.4%)
Dec 2024
$2.77M(+4.7%)
$2.77M(-4.0%)
Sep 2024
-
$2.89M(+6.7%)
Jun 2024
-
$2.71M(-1.2%)
Mar 2024
-
$2.74M(+3.5%)
Dec 2023
$2.65M(+11.8%)
$2.65M(+16.0%)
Sep 2023
-
$2.28M(-9.8%)
Jun 2023
-
$2.53M(+1.6%)
Mar 2023
-
$2.49M(+5.1%)
Dec 2022
$2.37M(+30.2%)
$2.37M(+7.9%)
Sep 2022
-
$2.20M(+2.9%)
Jun 2022
-
$2.13M(+2.5%)
Mar 2022
-
$2.08M(+14.4%)
Dec 2021
$1.82M(-94.2%)
$1.82M(-94.2%)
Sep 2021
-
$31.45M(+1.5%)
Jun 2021
-
$30.98M(-0.1%)
Mar 2021
-
$31.00M(-0.6%)
Dec 2020
$31.18M(-22.0%)
$31.18M(-37.6%)
Sep 2020
-
$49.96M(+0.1%)
Jun 2020
-
$49.93M(+11.0%)
Mar 2020
-
$45.00M(+12.6%)
Dec 2019
$39.96M(+18.4%)
$39.96M(+14.4%)
Sep 2019
-
$34.94M(+19.1%)
Jun 2019
-
$29.34M(+0.4%)
Mar 2019
-
$29.23M(-13.4%)
Dec 2018
$33.75M(-4.2%)
$33.75M(+9.9%)
Sep 2018
-
$30.70M(-13.5%)
Jun 2018
-
$35.51M(+0.4%)
Mar 2018
-
$35.37M(+0.4%)
Dec 2017
$35.22M(+24.7%)
$35.22M(+5.5%)
Sep 2017
-
$33.37M(+6.1%)
Jun 2017
-
$31.46M(+6.2%)
Mar 2017
-
$29.63M(+4.9%)
DateAnnualQuarterly
Dec 2016
$28.24M(+1.6%)
$28.24M(+0.4%)
Sep 2016
-
$28.13M(+0.4%)
Jun 2016
-
$28.02M(+0.4%)
Mar 2016
-
$27.91M(+0.4%)
Dec 2015
$27.80M(-7.3%)
$27.80M(-7.3%)
Sep 2015
-
$30.00M(0.0%)
Jun 2015
-
$30.00M(0.0%)
Mar 2015
-
$30.00M(0.0%)
Dec 2014
$30.00M(>+9900.0%)
$30.00M(0.0%)
Sep 2014
-
$30.00M(0.0%)
Jun 2014
-
$30.00M(>+9900.0%)
Dec 2013
$0.00(-100.0%)
$0.00(-100.0%)
Mar 2001
-
$3000.00(-69.4%)
Dec 2000
$9800.00(-90.2%)
$9800.00(-42.4%)
Sep 2000
-
$17.00K(-26.1%)
Jun 2000
-
$23.00K(-12.5%)
Mar 2000
-
$26.30K(-73.7%)
Dec 1997
$100.00K(-50.0%)
$100.00K(0.0%)
Sep 1997
-
$100.00K(0.0%)
Jun 1997
-
$100.00K(-50.0%)
Mar 1997
-
$200.00K(0.0%)
Dec 1996
$200.00K(-33.3%)
$200.00K(-33.3%)
Sep 1996
-
$300.00K(0.0%)
Jun 1996
-
$300.00K(0.0%)
Mar 1996
-
$300.00K(0.0%)
Dec 1995
$300.00K(0.0%)
$300.00K(0.0%)
Sep 1995
-
$300.00K(+50.0%)
Jun 1995
-
$200.00K(0.0%)
Mar 1995
-
$200.00K(-33.3%)
Dec 1994
$300.00K
$300.00K(0.0%)
Sep 1994
-
$300.00K(-25.0%)
Jun 1994
-
$400.00K(0.0%)
Mar 1994
-
$400.00K

FAQ

  • What is BioCryst Pharmaceuticals annual short term debt?
  • What is the all time high annual short term debt for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals annual short term debt year-on-year change?
  • What is BioCryst Pharmaceuticals quarterly short term debt?
  • What is the all time high quarterly short term debt for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals quarterly short term debt year-on-year change?

What is BioCryst Pharmaceuticals annual short term debt?

The current annual short term debt of BCRX is $2.77M

What is the all time high annual short term debt for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high annual short term debt is $39.96M

What is BioCryst Pharmaceuticals annual short term debt year-on-year change?

Over the past year, BCRX annual short term debt has changed by +$124.00K (+4.68%)

What is BioCryst Pharmaceuticals quarterly short term debt?

The current quarterly short term debt of BCRX is $2.87M

What is the all time high quarterly short term debt for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high quarterly short term debt is $49.96M

What is BioCryst Pharmaceuticals quarterly short term debt year-on-year change?

Over the past year, BCRX quarterly short term debt has changed by +$126.00K (+4.60%)
On this page